Author

L. Trilla-Fuertes

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 4 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 5 Approach:statistical model· 5 Research Focus:differential expression· 3 Assay:proteomics· 3 Assay:bulk RNA-seq· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:clustering· 1

Frequent Co-Authors

A. Gamez-Pozo· 5 shared A. Zapater-Moros· 4 shared G. Prado-Vazquez· 4 shared R. Lopez-Vacas· 4 shared E. Espinosa· 3 shared E. Lopez-Camacho· 3 shared J. A. Fresno Vara· 3 shared M. Diaz-Almiron· 3 shared

Activity by Year

2018-2020 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 41 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

5 shared papersCancer Biology

A. Gamez-Pozo

Mutual co-authors in cluster

Author profile →

5 papers

Recent·Most cited

Molecular characterization of triple negative breast cancer formaldehyde-fixed paraffin-embedded samples by data independent acquisition proteomics

S. Garcia-Adrian, L. Trilla-Fuertes, A. Gamez-Pozo, C. Chiva, R. Lopez-Vacas, E. Lopez-Camacho, G. Prado-Vazquez, A. Zapater-Moros, M. I. Lumbreras-Herrera, D. Hardisson, L. Yebenes, P. Zamora, E. Sabido, J. A. Fresno Vara, E. Espinosa

This study uses proteomics to identify molecular subgroups and a prognostic signature in triple negative breast cancer samples, revealing differences in biological processes and potential therapeutic targets.

bioRxiv · Sep 21, 2020Cancer Biology

Functional characterization of SARS-CoV-2 infection suggests a complex inflammatory response and metabolic alterations

L. Trilla-Fuertes, R. Ramos-Ruiz, N. Blanca-Lopez, E. Lopez-Camacho, L. Martin-Pedraza, P. Ryan Murua, M. Diaz-Almiron, C. Llorens, T. Gabaldon, A. Moya, J. A. Fresno, A. Gamez-Pozo

This study analyzes RNAseq data from COVID-19 patients and healthy controls to identify inflammatory and metabolic changes associated with SARS-CoV-2 infection.

bioRxiv · Jun 22, 2020 · PreprintMicrobiology

Comprehensive characterization of the mutational landscape in localized anal squamous cell carcinoma

L. Trilla-Fuertes, I. Ghanem, J. Maurel, L. G-Pastrian, M. Mendiola, C. Pena, R. Lopez-Vacas, G. Prado-Vazquez, E. Lopez-Camacho, A. Zapater-Moros, V. Heredia, M. Cuatrecasas, P. Garcia-Alfonso, J. Capdevila, C. Conill, , J. A. Fresno

This study identifies high-impact genetic variants in anal squamous cell carcinoma and links some to poor prognosis.

bioRxiv · Oct 7, 2019Cancer Biology

Computational metabolism modeling predicts risk of distant relapse-free survival in breast cancer patients

L. Trilla-Fuertes, A. Gamez-Pozo, M. Diaz-Almiron, G. Prado-Vazquez, A. Zapater-Moros, R. Lopez-Vacas, P. Nanni, P. Zamora, E. Espinosa, J. A. Fresno Vara

The paper uses flux balance analysis on proteomics data to identify metabolic pathways associated with prognosis in breast cancer patients.

bioRxiv · Nov 12, 2018Cancer Biology

Bayesian Networks established functional differences between breast cancer subtypes

L. Trilla-Fuertes, A. Zapater-Moros, A. Gamez-Pozo, J. M. Arevalillo, G. Prado-Vazquez, M. Diaz-Almiron, M. Ferrer-Gomez, R. Lopez-Vacas, H. Navarro, E. Espinosa, P. Main, J. A. Fresno Vara

The paper uses Bayesian networks and proteomics data to identify functional differences between breast cancer subtypes, including a new TN-like subtype, and finds a metastasis-related component with prognostic value.

bioRxiv · May 18, 2018Cancer Biology